Bulletin
Investor Alert

New York Markets Close in:

Merck & Co. Inc.

NYS: MRK

GO
/marketstate/country/us

Market open

MRK
/zigman2/quotes/209956077/composite

$

79.08

Change

-0.38 -0.48%

Volume

Volume 5.39m

Jan 26, 2022, 1:53 p.m.

Real time quotes

/zigman2/quotes/209956077/composite

Previous close

$ 79.46

$ 79.08

Change

-0.38 -0.48%

Day low

Day high

$78.94

$80.34

Open
Open: 79.39

52 week low

52 week high

$68.38

$91.40

Open

Market cap

$200.71B

Average volume

13.54M

P/E ratio

27.89

Rev. per Employee

$660,851

EPS

2.83

Dividend

0.65

Div yield

3.49%

Ex dividend date

6/14/21

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/mrk

MarketWatch News on MRK

  1. Johnson & Johnson stock outperforms market on strong trading day

    4:32 p.m. Jan. 25, 2022

    - MarketWatch Automation

  2. How Omicron Is Changing Vaccine and Therapeutic Strategies

    10:10 a.m. Jan. 25, 2022

    - Josh Nathan-Kazis

  3. FDA halts use of antibody drugs that don’t work against omicron

    6:04 p.m. Jan. 24, 2022

    - Associated Press

  4. Johnson & Johnson stock falls Monday, underperforms market

    4:32 p.m. Jan. 24, 2022

    - MarketWatch Automation

  5. Johnson & Johnson stock outperforms competitors despite losses on the day

    4:32 p.m. Jan. 21, 2022

    - MarketWatch Automation

  6. Johnson & Johnson stock outperforms market despite losses on the day

    4:32 p.m. Jan. 20, 2022

    - MarketWatch Automation

  7. Johnson & Johnson stock underperforms Wednesday when compared to competitors

    4:32 p.m. Jan. 19, 2022

    - MarketWatch Automation

  8. Johnson & Johnson stock outperforms market despite losses on the day

    4:32 p.m. Jan. 18, 2022

    - MarketWatch Automation

  9. Merck and Ridgeback Biotherapeutics to supply 3 mln doses of COVID antiviral to Unicef in 2022

    6:46 a.m. Jan. 18, 2022

    - Ciara Linnane

  10. Johnson & Johnson stock falls Friday, underperforms market

    4:32 p.m. Jan. 14, 2022

    - MarketWatch Automation

  11. Johnson & Johnson stock falls Thursday, still outperforms market

    4:32 p.m. Jan. 13, 2022

    - MarketWatch Automation

  12. Johnson & Johnson stock underperforms Wednesday when compared to competitors

    4:32 p.m. Jan. 12, 2022

    - MarketWatch Automation

  13. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/mrk

Other News on MRK

  1. 2 Growth Stocks Down 21% to 39% That Could Soar, According to Wall Street

    11:15 a.m. Today

    - Motley Fool

  2. 2 Stocks to Buy No Matter What Happens in 2022

    8:51 a.m. Today

    - Motley Fool

  3. Is Merck's new COVID-19 pill enough to make the stock a buy?

    8:25 a.m. Today

    - Seeking Alpha

  4. Wednesday’s Premarket: 5 S&P 500 Winners, 5 Losers

    7:08 a.m. Today

    - 247WallSt.com

  5. Is Invesco Dynamic Pharmaceuticals ETF (PJP) a Strong ETF Right Now?

    6:20 a.m. Today

    - Zacks.com

  6. Tracking Kahn Brothers Portfolio - Q4 2021 Update

    9:59 p.m. Jan. 25, 2022

    - Seeking Alpha

  7. Merck's (MRK) Chronic Cough Drug Gets CRL From FDA

    11:13 a.m. Jan. 25, 2022

    - Zacks.com

  8. Loading more headlines...
/news/pressrelease/company/us/mrk

Press Releases on MRK

  1. Daily Dividend Report: WFC,SYF,PAG,MRK,GWW

    12:00 p.m. Today

    - MarketNewsVideo.com

  2. Merck Announces Second-Quarter 2022 Dividend

    1:34 p.m. Jan. 25, 2022

    - BusinessWire - BZX

  3. effector Scores Loan From Lincoln Park

    10:12 a.m. Jan. 25, 2022

    - Baystreet.ca

  4. Merck Provides U.S. and Japan Regulatory Update for Gefapixant

    6:45 a.m. Jan. 24, 2022

    - BusinessWire - BZX

  5. When Merck (MRK) Moves Investors should Listen

    1:32 a.m. Jan. 22, 2022

    - Stock Traders Daily

  6. Friday's ETF with Unusual Volume: IYH

    1:48 p.m. Jan. 21, 2022

    - MarketNewsVideo.com

  7. Frank Clyburn to Leave Merck

    7:09 a.m. Jan. 20, 2022

    - BusinessWire - BZX

  8. Rapid Microbiology Testing Market Therapeutic Survey Reviews, Analysis 2026

    8:54 a.m. Jan. 19, 2022

    - Market Insight Reports

  9. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/200030751/composite CLSK-1.06%
  • /zigman2/quotes/228559245/composite ADGI-78.81%
  • /zigman2/quotes/216531076/composite ESSC-26.63%
  • /zigman2/quotes/211617595/composite BYND+9.29%
  • /zigman2/quotes/205021014/composite RUN-15.70%
X
Powered by StockTwits
Link to MarketWatch's Slice.